ReposiTrak (NYSE:TRAK) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut shares of ReposiTrak (NYSE:TRAK) from a buy rating to a hold rating in a research report sent to investors on Friday morning.

Separately, Weiss Ratings restated a “hold (c+)” rating on shares of ReposiTrak in a report on Saturday, September 27th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company currently has an average rating of “Hold”.

ReposiTrak Stock Performance

Shares of TRAK stock opened at $14.91 on Friday. The business’s 50 day simple moving average is $16.63. ReposiTrak has a 52-week low of $13.86 and a 52-week high of $25.01. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.09 and a quick ratio of 6.09. The company has a market cap of $272.55 million, a price-to-earnings ratio of 42.60 and a beta of 0.44.

ReposiTrak (NYSE:TRAK) last released its earnings results on Monday, September 29th. The company reported $0.09 earnings per share for the quarter. ReposiTrak had a return on equity of 14.25% and a net margin of 30.55%.The business had revenue of $5.76 million for the quarter.

Insider Buying and Selling at ReposiTrak

In other news, CEO Randall K. Fields sold 4,700 shares of the stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $15.71, for a total transaction of $73,837.00. Following the transaction, the chief executive officer owned 57,500 shares of the company’s stock, valued at approximately $903,325. This represents a 7.56% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In the last three months, insiders sold 86,500 shares of company stock valued at $1,480,274. 44.00% of the stock is currently owned by corporate insiders.

Institutional Trading of ReposiTrak

Hedge funds have recently added to or reduced their stakes in the business. BNP Paribas Financial Markets grew its holdings in ReposiTrak by 63.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock worth $32,000 after acquiring an additional 634 shares in the last quarter. Tower Research Capital LLC TRC lifted its position in shares of ReposiTrak by 397.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock worth $71,000 after purchasing an additional 2,892 shares during the period. R Squared Ltd bought a new position in shares of ReposiTrak during the second quarter valued at approximately $235,000. Rhumbline Advisers increased its holdings in ReposiTrak by 69.1% during the second quarter. Rhumbline Advisers now owns 18,036 shares of the company’s stock valued at $354,000 after buying an additional 7,371 shares during the period. Finally, Coldstream Capital Management Inc. raised its stake in ReposiTrak by 47,619.0% in the second quarter. Coldstream Capital Management Inc. now owns 20,042 shares of the company’s stock worth $394,000 after buying an additional 20,000 shares in the last quarter. 27.35% of the stock is owned by hedge funds and other institutional investors.

ReposiTrak Company Profile

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.